Compare BWXT & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWXT | WST |
|---|---|---|
| Founded | 1867 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 18.5B |
| IPO Year | 2010 | 2004 |
| Metric | BWXT | WST |
|---|---|---|
| Price | $217.70 | $275.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $209.70 | ★ $320.86 |
| AVG Volume (30 Days) | ★ 898.8K | 744.3K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.50% | 0.32% |
| EPS Growth | ★ 16.61 | 1.49 |
| EPS | 3.58 | ★ 6.79 |
| Revenue | $1,687,738,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $20.47 | $6.76 |
| Revenue Next Year | $9.50 | $6.25 |
| P/E Ratio | $60.69 | ★ $40.62 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $102.42 | $199.89 |
| 52 Week High | $241.82 | $322.34 |
| Indicator | BWXT | WST |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 67.24 |
| Support Level | $187.96 | $262.93 |
| Resistance Level | $219.10 | $278.04 |
| Average True Range (ATR) | 8.36 | 6.49 |
| MACD | -1.16 | 1.70 |
| Stochastic Oscillator | 35.81 | 82.67 |
BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.